Atlas Trials

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Clinical trial NCT04195919 · COMPLETED

Trial details

NCT number
NCT04195919
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemodialysis Patients
Start date
2020-07-10
Primary completion
2021-05-24
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.